Charles River Laboratories International, Inc. (CRL)
NYSE·Healthcare·Medical - Diagnostics & Research
$235.35
+1.94%
Mkt Cap $11.12B
Analyst Ratings
Buy
9
Hold
5
Sell
0
Price Target (43 analysts)
$222.11
Range $192.00 – $250.00
Implied Upside
-5.6%
Consensus $222.11 vs current $235.35